Home / Clinical Research
Claims that we can SUPPORT and VERIFY that's PUBLISHED!
"We are excited to get it out, where people can actually benefit from it"

Clinical Trial Results Have Shown

It is absorbed through the skin and penetrates the joints with soothing relief from pain and inflammation. Unlike sports rubs, which may simply increase blood circulation and produce a very temporary cessation of pain, this works more gradually over a few weeks to produce long-lasting relief. With an increased range of motion, users experience a restored quality of life, free from the debilitating limitations of osteoarthritis.

A dual center, pivotal Phase III, randomized controlled trial using Acteev® technology for knee osteoarthritis pain, inflammation, and cartilage breakdown markers (Prof. Graeme Jones, Menzies Research Institute of Musculoskeletal Disease, Hobart) confirmed:

“This is superior to placebo for OA knee pain at 12 weeks” by both the Visual Analogue pain Score (VAS) and the Knee injury and Osteoarthritis Outcome Score (KOOS).

This study confirmed the findings of a prior published pilot study by Oklahoma State University, an Open Label Trial in New Zealand and a considerable body of anecdotal evidence.

Committment To Clinical Research
Proven and Repeatable Results
Double-Blind Placebo-Controlled Study 4Jointz Oklahoma State University
Double Blind Placebo Controlled Study
Double-blind, placebo-controlled clinical trial under the auspices of Oklahoma State University, Oklahoma, USA.
Phase III Clinical Trial Menzies Institute
Phase III Clinical Trial
Phase III Clinical Trial (The Menzies Research Institute of Musculosketal Disease, University of Tasmania & The Royal North Shore Hospital Campus, Northern Sydney, Australia)
ARP Post Market Survey
Arthritis Relief Plus (ARP) Open-Label Study
ARP 'open-label' study (under the brand name 4Jointz®) undertaken for safety and efficacy in multiple joints in New Zealand Applied Science and Nutrition.

Prof. Graeme Jones 4Jointz
ECCEO Poster Presenatation
Professor Graeme Jones presents at ECCEO Bordeaux France: Treatment with 4Jointz® reduces knee pain over twelve weeks of treatment in persons with clinical knee osteoarthritis.
Double-Blind Placebo Controlled, Exploratory Study
Double-Blind, placebo controlled, exploratory study at the Stanford Center of Longevity (SCL), Stanford USA, sponsored by SCL.
View more
View less

Movement is Freedom

Clinical Trial results of 4JOINTZ® have shown:

  • A statistically significant reduction in pain and swelling.
  • A statistically significant increase in mobility and leg strength.
  • A meaningful reduction of 400mg per day usage of acetaminophen (paracetamol).
  • Long-lasting results!
  • An overall improved quality of life!

The best product for joints is here. It is proven, unique and one of a kind. Get your's today and experience the freedom to move.